Multisystemic Diseases

Group leader

Luis Manzano Espinosa

luis.manzano(ELIMINAR)@salud.madrid.org

91 336 92 04

Principal Investigators

  • José Sabán Ruiz
  • Vicente Gómez del Olmo

Collaborators

  • Olivia Sánchez Sánchez
  • José Luis Patier de la Peña
  • Mónica Angélica López Rodríguez
  • Ángel Ruedas López
  • Ignacio Barbolla Díaz
  • Nuria Bara Ledesma
  • Martín Fabregate Fuente
  • Andrés González García
  • Eduardo Montero Ruiz
  • María Belén Pumares Álvarez
  • Myriam Mª Moralejo Martín
  • Sonia Cano Tébar
  • Rosa María Fabregate Fuente
  • Evelyn Iveth Ortiz Barraza
  • Raúl Antonio Ruiz Ortega

Group leader

Luis Manzano Espinosa

luis.manzano(ELIMINAR)@salud.madrid.org

91 336 92 04

Principal Investigators

  • José Sabán Ruiz
  • Vicente Gómez del Olmo

Collaborators

  • Olivia Sánchez Sánchez
  • José Luis Patier de la Peña
  • Mónica Angélica López Rodríguez
  • Ángel Ruedas López
  • Ignacio Barbolla Díaz
  • Nuria Bara Ledesma
  • Martín Fabregate Fuente
  • Andrés González García
  • Eduardo Montero Ruiz
  • María Belén Pumares Álvarez
  • Myriam Mª Moralejo Martín
  • Sonia Cano Tébar
  • Rosa María Fabregate Fuente
  • Evelyn Iveth Ortiz Barraza
  • Raúl Antonio Ruiz Ortega

STRATEGIC OBJECTIVES

  • Advance in the knowledge of the pathophysiological mechanisms involved in different multisystemic diseases.
  • Identify biomarkers and potential therapeutic targets, as well as to develop prognostic models with clinical application in both acute or chronic complex pathologies.
  • Develop, apply and evaluate new technologies and diagnostic and therapeutic tools, as well as new prevention and treatment strategies, in patients with complex pathologies.
  • Promote synergies between the different research lines of the Group, and collaborate with other groups, researchers and structures of IRYCIS.
  • Integration and active participation in cooperative networks, working groups and multicenter, national and international registries.
  • Strengthen and expand alliances and collaborations with the business sector in clinical research.
  • Generate new and complementary with current ones' research lines, in line with the strategic objectives of IRYCIS and national and European research agendas.

RESEARCH LINES

  • Heart failure in complex chronic patients
  • Pathophysiological and therapeutic bases of cardiovascular prevention
  • Venous thromboembolism prophylaxis
  • Hereditary hemorrhagic telangiectasia
  • Inherited metabolic diseases in adults
  • Systemic autoimmune diseases
  • Hemato-oncological diseases in elderly patients
  • Evaluation of shared care results in multimorbid patients

Location

Ramón y Cajal University Hospital 

Internal Medicine Department

4th Floor, right side. Control B

Keywords

Multisystemic diseases; heart failure; complex chronic patient; cardiovascular prevention; venous thromboembolism; systemic autoimmune diseases; minority diseases; hereditary hemorrhagic telangiectasia; congenital metabolic diseases in adults; hemato-oncological diseases; elderly patient; shared care; multipathological patient.